mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for ERBB4
Gene summary
Basic gene Info.Gene symbolERBB4
Gene nameerb-b2 receptor tyrosine kinase 4
SynonymsALS19|HER4|p180erbB4
CytomapUCSC genome browser: 2q33.3-q34
Type of geneprotein-coding
RefGenesNM_001042599.1,
NM_005235.2,
Descriptionavian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4human epidermal growth factor receptor 4proto-oncogene-like protein c-ErbB-4receptor tyrosine-protein kinase erbB-4tyrosine kinase-type cell surface receptor HER4v-erb-a erythroblastic
Modification date20141220
dbXrefs MIM : 600543
HGNC : HGNC
Ensembl : ENSG00000178568
HPRD : 02767
Vega : OTTHUMG00000133012
ProteinUniProt: Q15303
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_ERBB4
BioGPS: 2066
PathwayNCI Pathway Interaction Database: ERBB4
KEGG: ERBB4
REACTOME: ERBB4
Pathway Commons: ERBB4
ContextiHOP: ERBB4
ligand binding site mutation search in PubMed: ERBB4
UCL Cancer Institute: ERBB4
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0007165signal transduction10572067
GO:0007169transmembrane receptor protein tyrosine kinase signaling pathway10353604
GO:0016477cell migration9135143
GO:0018108peptidyl-tyrosine phosphorylation18334220
GO:0043552positive regulation of phosphatidylinositol 3-kinase activity10353604
GO:0043552positive regulation of phosphatidylinositol 3-kinase activity10353604
GO:0046777protein autophosphorylation18334220


Top
Ligand binding site mutations for ERBB4
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
K751K751QCOAD2
E112R114QCOAD1
F862F862LHNSC1
V732T731MHNSC1
E806E806DHNSC1
M799M799LKIRC1
L850V849ILUAD1
L864R866KLUAD1
E806L805VLUAD1
F120A118SLUAD1
G802G802VLUAD1
S67E69KLUSC1
M799P800SLUSC1
D126G127ESKCM1
E112R114QSKCM1
E112D113NSKCM1
M799P800LSKCM1
Q151D150NSKCM1
G802G802CSTAD1
R488R488WSTAD1
K51R50SSTAD1
L798L798PSTAD1
Q44Y46CSTAD1
M772S774GSTAD1
K51R50HUCEC1
K751K751TUCEC1
M772I771TUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.

Clinical information for ERBB4 from My Cancer Genome.
Erb-b2 receptor tyrosine kinase 4 (ERBB4) is a gene that encodes a receptor tyrosine kinase in the epidermal growth factor family. Missense mutations, nonsense mutations, silent mutations, and frameshift deletions are observed in cancers such as endometrial cancer, intestinal cancer, and stomach cancer. Related Pathways: Receptor tyrosine kinase/growth factor signaling. Modified: December 4, 2015

Top
Protein structure related information for ERBB4
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
G802G802V0.26082605
F862F862L0.16624251
G802G802C0.15686022
S67E69K-1.616035
M799P800S-1.6150644
L798L798P-1.5726942
E806E806D-1.4953462
E112R114Q-1.299852
M772I771T-1.2588263
M772S774G-1.2228344
R488R488W-1.0152976
M799P800L-0.98959059
L864R866K-0.87476052
K51R50H-0.850506
K51R50S-0.84747852
E112D113N-0.78861658
D126G127E-0.7606142
Q151D150N-0.63053544
M799M799L-0.62622144
L850V849I-0.57757173
F120A118S-0.56474251
Q44Y46C-0.54714339
E806L805V-0.39264725
K751K751T-0.31258994
K751K751Q-0.2981069
V732T731M-0.17851682
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for ERBB4 from PDB
PDB IDPDB titlePDB structure
3BCECrystal structure of the ErbB4 kinase

Top
Differential gene expression and gene-gene network for ERBB4
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of ERBB4 and the right PPI network was created from samples without mutations in the LBS of ERBB4. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for ERBB4
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0025202Melanoma10Biomarker, GeneticVariation
umls:C3715155AMYOTROPHIC LATERAL SCLEROSIS 191GeneticVariation
umls:C0037286Skin Neoplasms1Biomarker, GeneticVariation
umls:C0016978Gallbladder Neoplasms1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for ERBB4
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
ApprovedDB08916AfatinibSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of ERBB4 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
GW7N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-ETHYLTHIENO[3,2-D]PYRIMIDIN-4-AMINE2r4bAV732 K751 M772 L798 M799 G802 L850 F862
GW7N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-ETHYLTHIENO[3,2-D]PYRIMIDIN-4-AMINE2r4bBV732 K751 M772 M799 G802 E806 L850 F862 L864


Top
Conservation information for LBS of ERBB4
Multiple alignments for Q15303 in multiple species
LBSAA sequence# speciesSpecies
A749VKIPVAIKILN3Homo sapiens, Mus musculus, Rattus norvegicus
C803LMPHGCLLEYV2Homo sapiens, Rattus norvegicus
C803LMPHGCLLDYV1Mus musculus
D126LNYRKDGNFGL3Homo sapiens, Mus musculus, Rattus norvegicus
D376TGIHGDPYNAI3Homo sapiens, Mus musculus, Rattus norvegicus
D41LSSLSDLEQQY3Homo sapiens, Mus musculus, Rattus norvegicus
D861HVKITDFGLAR3Homo sapiens, Mus musculus, Rattus norvegicus
E112GTKLYEDRYAL3Homo sapiens, Mus musculus, Rattus norvegicus
E806HGCLLEYVHEH2Homo sapiens, Rattus norvegicus
E806HGCLLDYVHEH1Mus musculus
F120YALAIFLNYRK3Homo sapiens, Mus musculus, Rattus norvegicus
F862VKITDFGLARL3Homo sapiens, Mus musculus, Rattus norvegicus
G802QLMPHGCLLEY2Homo sapiens, Rattus norvegicus
G802QLMPHGCLLDY1Mus musculus
I750KIPVAIKILNE3Homo sapiens, Mus musculus, Rattus norvegicus
K125FLNYRKDGNFG3Homo sapiens, Mus musculus, Rattus norvegicus
K35AGTENKLSSLS3Homo sapiens, Mus musculus, Rattus norvegicus
K438SLLILKQQGIT3Homo sapiens, Mus musculus, Rattus norvegicus
K51YRALRKYYENC3Homo sapiens, Mus musculus, Rattus norvegicus
K751IPVAIKILNET3Homo sapiens, Mus musculus, Rattus norvegicus
L121ALAIFLNYRKD3Homo sapiens, Mus musculus, Rattus norvegicus
L36GTENKLSSLSD3Homo sapiens, Mus musculus, Rattus norvegicus
L369GNLIFLVTGIH3Homo sapiens, Mus musculus, Rattus norvegicus
L39NKLSSLSDLEQ3Homo sapiens, Mus musculus, Rattus norvegicus
L42SSLSDLEQQYR3Homo sapiens, Mus musculus, Rattus norvegicus
L435SGLSLLILKQQ3Homo sapiens, Mus musculus, Rattus norvegicus
L437LSLLILKQQGI3Homo sapiens, Mus musculus, Rattus norvegicus
L783PHLVRLLGVCL3Homo sapiens, Mus musculus, Rattus norvegicus
L794SPTIQLVTQLM3Homo sapiens, Mus musculus, Rattus norvegicus
L798QLVTQLMPHGC3Homo sapiens, Mus musculus, Rattus norvegicus
L850AARNVLVKSPN3Homo sapiens, Mus musculus, Rattus norvegicus
L864ITDFGLARLLE3Homo sapiens, Mus musculus, Rattus norvegicus
L91YVLVALNQFRY3Homo sapiens, Mus musculus, Rattus norvegicus
M772DEALIMASMDH2Homo sapiens, Mus musculus
M772DEALIMASVDH1Rattus norvegicus
M799LVTQLMPHGCL3Homo sapiens, Mus musculus, Rattus norvegicus
N34CAGTENKLSSL3Homo sapiens, Mus musculus, Rattus norvegicus
N379HGDPYNAIDAI2Mus musculus, Rattus norvegicus
N379HGDPYNAIEAI1Homo sapiens
Q151GVYVDQNKFLC3Homo sapiens, Mus musculus, Rattus norvegicus
Q346SLMSAQTVDSS3Homo sapiens, Mus musculus, Rattus norvegicus
Q405GFLNIQSWPPN2Homo sapiens, Mus musculus
Q405GFLNIQTWPPN1Rattus norvegicus
Q44LSDLEQQYRAL3Homo sapiens, Mus musculus, Rattus norvegicus
Q797IQLVTQLMPHG3Homo sapiens, Mus musculus, Rattus norvegicus
R484STINQRIVIRD2Homo sapiens, Mus musculus
R484STVNQRIVIRD1Rattus norvegicus
R488QRIVIRDNRRA2Mus musculus, Rattus norvegicus
R488QRIVIRDNRKA1Homo sapiens
R782HPHLVRLLGVC3Homo sapiens, Mus musculus, Rattus norvegicus
S37TENKLSSLSDL3Homo sapiens, Mus musculus, Rattus norvegicus
S38ENKLSSLSDLE3Homo sapiens, Mus musculus, Rattus norvegicus
S40KLSSLSDLEQQ3Homo sapiens, Mus musculus, Rattus norvegicus
S67NLEITSIEHNR3Homo sapiens, Mus musculus, Rattus norvegicus
T371LIFLVTGIHGD3Homo sapiens, Mus musculus, Rattus norvegicus
T796TIQLVTQLMPH3Homo sapiens, Mus musculus, Rattus norvegicus
T860NHVKITDFGLA3Homo sapiens, Mus musculus, Rattus norvegicus
V370NLIFLVTGIHG3Homo sapiens, Mus musculus, Rattus norvegicus
V732GAFGTVYKGIW3Homo sapiens, Mus musculus, Rattus norvegicus
V781DHPHLVRLLGV3Homo sapiens, Mus musculus, Rattus norvegicus
Y111RGTKLYEDRYA3Homo sapiens, Mus musculus, Rattus norvegicus
Y123AIFLNYRKDGN3Homo sapiens, Mus musculus, Rattus norvegicus
Y148LNGGVYVDQNK3Homo sapiens, Mus musculus, Rattus norvegicus
Y378IHGDPYNAIDA2Mus musculus, Rattus norvegicus
Y378IHGDPYNAIEA1Homo sapiens
Y429GGRVLYSGLSL3Homo sapiens, Mus musculus, Rattus norvegicus
Y459SAGNIYITDNS3Homo sapiens, Mus musculus, Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas